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In Brief
Vadia et al. identify lipid synthesis as a primary and conserved determinant of plasma membrane capacity and size in bacteria and yeast. This finding highlights a distinct role for anabolic metabolism in setting cell size and provides insight into the positive relationship between nutrient availability and size that exists across the tree of life.
INTRODUCTION
Cell size control is a fundamental aspect of biology. In multicellular organisms differences in cell size frequently dictate developmental fate, and defects in cell size are associated with cancer and other disease states [1] . In single-celled organisms, defects in cell size can be catastrophic, leading to failures in chromosome partitioning, bisection of genomic material during cytokinesis, and cell death [2, 3] .
With the exception of asymmetric division and the formation of syncytia, cell size is dictated by two parameters: growth rate and cell-cycle progression. Balancing these two parameters ensures cell size is maintained, an idea supported by the recent discovery that bacterial cells cultured under steady-state conditions add a constant volume (D) prior to division regardless of their size at birth [4, 5] . Changes in growth conditions that alter this balance lead to adjustments in cell size.
Research on cell size has historically focused on the role of the cell cycle. Most famously, the wee1 kinase from Schizosaccharomyces pombe influences the timing of mitosis to maintain cell size, a function conserved in its many eukaryotic homologs [6] . In bacteria including the evolutionarily distant model organisms Escherichia coli and Bacillus subtilis, cell size is coupled with carbon availability in part via the uridine diphosphate (UDP)-glucose-dependent activation of a division inhibitor that delays the onset of cytokinesis [2, 3] . Growth-dependent accumulation of the DNA replication initiation factor DnaA has also been implicated in cell size control via its impact on the timing and frequency of replication initiation [7, 8] .
Several lines of evidence support the idea that biosynthetic capacity, a product of nutrient availability, also serves as a primary determinant of cell size. Most important among these is the positive correlation between nutrient availability and cell size that exists throughout the tree of life [9] . The relationship between cell size, nutrient availability, and growth rate is exponential in Salmonella enterica, E. coli, and B. subtilis. In all three species, cells cultured under nutrient-rich conditions are up to three times larger than those cultured under nutrient-poor conditions, a size increase too great to be accounted for solely by UDP-glucose-dependent division inhibition [2, 3, [10] [11] [12] . Significantly, D, the volume of material that E. coli cells add each generation, changes with carbon availability, suggesting that changes in biosynthetic capacity shift the balance between growth rate and the rate of cell-cycle progression [4, 5] .
In further support of biosynthetic capacity as an important determinant of cell size, accumulation of guanosine tetraphosphate (ppGpp), a pleiotropic inhibitor of biosynthetic pathways, is negatively correlated with bacterial size. Increasing ppGpp concentration directly via overexpression of the ppGpp synthase RelA reduces the growth rate and size of E. coli [13] . Indirect stimulation of ppGpp accumulation via amino acid starvation or by limiting fatty acid synthesis similarly leads to reductions in both growth rate and cell size [14] [15] [16] .
Because ppGpp is a global regulator of biosynthesis, it is unclear whether ppGpp-dependent reductions in size are the result of changes in global biosynthetic capacity. Although amino acid starvation or limitations in fatty acid synthesis may directly affect cell size, it is equally likely that they impact size indirectly via increases in ppGpp concentration and the concomitant global downregulation of biosynthetic capacity. This precise conundrum was noted by Yao et al., who reported a reduction in E. coli size associated with defects in fabH, whose product is required for an early step in fatty acid synthesis [15] .
To illuminate the role of biosynthetic capacity in cell size control, we assessed the contribution of three major anabolic pathways to E. coli morphology and growth rate. Our data unequivocally and for the first time establish fatty acid synthesis as a primary, ppGpp-independent determinant of E. coli cell size. Not only did increasing fatty acid synthesis lead to dramatic ppGpp-independent increases in cell size, but defects in other pathways impacted by ppGpp either caused a slight increase in cell size (RNA synthesis) or reduced size in a fatty acid-dependent manner (protein synthesis). Significantly, our data point to an evolutionarily conserved role for fatty acids as a positive determinant of cell size, as curtailing fatty acid synthesis also significantly reduced the size of the Gram-positive bacterium Bacillus subtilis and the unicellular eukaryote S. cerevisiae.
Our findings support a novel ''outside-in'' model in which size is dictated by the capacity of the cell envelope, which is itself a product of nutrient-dependent changes in fatty acid synthesis and availability. This lipid-centric view has implications for essentially all aspects of bacterial physiology that are sensitive to changes in nutrient availability. In particular, cell envelope biogenesis must be coordinated with synthesis of cytoplasmic material to ensure that cytoplasmic volume does not exceed cell envelope capacity. Our data suggest that ppGpp plays a central role in this process, tethering lipid synthesis to cytoplasmic aspects of anabolic metabolism to preserve cell envelope integrity in response to a rapidly changing nutritional landscape.
RESULTS
RNA, Protein, and Fatty Acid Synthesis Differentially Impact Cell Size To identify the major biosynthetic pathways contributing to cell size, we modified the growth rate of E. coli cultured in nutrientrich medium (lysogeny broth [LB] + 0.2% glucose; LB-glc) with subinhibitory concentrations of antibiotics targeting RNA (rifampicin), protein (chloramphenicol), and fatty acid (cerulenin) synthesis. All three anabolic pathways are downregulated in response to increases in ppGpp levels, either directly (RNA) or indirectly (protein and fatty acid synthesis) [17] [18] [19] . In light of the association between defects in DNA replication and both SOS-dependent and -independent modes of division inhibition, we elected not to investigate the impact of reducing DNA synthesis [20, 21] . We similarly chose not to examine the effect of cell wall biogenesis inhibitors, as antibiotics targeting peptidoglycan synthesis frequently disrupt division, leading to changes in morphology that make it difficult to assess their impact on cell size [22, 23] .
As a benchmark, we first modified growth by culturing cells in LB-glc, LB, and AB minimal medium with or without 0.5% casamino acids with 0.2% glucose or 0.4% succinate (AB-caa-glc, AB-caa-succ, AB-glc, and AB-succ). So that the impact of limitations in RNA, protein, or fatty acid synthesis on cell size could be assessed, E. coli [MG1655 P lac ::gfp-ftsZ (bla)] were cultured to early log phase in LB-glc, back-diluted into fresh medium with subinhibitory concentrations of the appropriate antibiotic plus 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) to induce expression from P lac -gfp-ftsZ, and cultured for five to six generations (OD 600 $0.15-0.3) prior to being fixed, imaged, and measured. Notably, we did not detect any significant differences in growth rate or cell size if chloramphenicol-or cerulenintreated cells were back diluted a second time and cultured for an additional six generations at the same concentrations. However, in the presence of the highest concentration of rifampicin, cells were unable to reach a substantial OD 600 , suggesting that robust transcription is a requirement for exit from early log growth (Table S2) .
Consistent with previous studies, reductions in nutrient availability led to decreases in both growth rate and size (Figures 1A and S1A; Table S1 ) [10] [11] [12] . E. coli cultured in LB-glc grew to a mean length (l) of 3.76 mm, mean width (w) of 1.07 mm, and mean square area (a) of 4.11 mm 2 , whereas those cultured in minimal succinate, the poorest carbon source, were shorter, thinner, and $50% smaller by area (a = 2.07 mm 2 , l = 2.63 mm, w = 0.79 mm).
Of the antibiotics, only cerulenin, an inhibitor of the b-ketoacyl-ACP synthase I FabB, reduced growth rate and size in a manner that mimicked the effects of nutrient limitation (Figures 1A and S1A; for reference, the carbon curve is depicted as a black line). The size and growth rate of cells cultured in LB-glc + 70 mg/ml of cerulenin were similar to those of cells cultured in AB-caa-glc (LB-glc + cer: doublings/hour [d/hr] = 1.36, l = 2.93 mm, w = 0.95 mm, a = 2.88 mm 2 ; AB-caa-glc: d/hr = 1.4, l = 2.56 mm, w = 0.96 mm, a = 2.44 mm 2 ). Although treatment with between 0.5 mg/ml and 1.5 mg/ml of chloramphenicol reduced cell length to 3.14 mm, width remained essentially constant ($1.0 to 1.1 mm). Inhibiting transcription with rifampicin significantly reduced growth rate, but not cell size. Instead, we observed a small but distinct increase in cell size at the highest concentrations of antibiotic. The 10% reduction in chloramphenicol-treated cell size is similar to that previously reported by the Jun laboratory [24] .
Although the three antibiotics differentially impacted cell size, none significantly disrupted the relationship between growth rate and cell-cycle progression. As a marker of cell-cycle progression, we determined the percentage of cells with a visible FtsZ ring, which serves as a framework for assembly of the division machinery at midcell [25] . Although 80%-90% of cells cultured in nutrient-rich medium have visible FtsZ rings, rings are present in only 40%-50% of their counterparts cultured in nutrient-poor medium, consistent with a reduced rate of cell-cycle progression [25, 26] . Although depressed relative to other growth conditions-potentially due to reduced expression of native ftsZ and P lac ::gfp-ftsZ-the frequency of FtsZ rings remained proportional to d/hr in rifampicin-treated cells ( Figure 1B) . Cell sizes and growth rates of wild-type and of P lac ::gfp-ftsZ E. coli were essentially identical, indicating that expression of gfp-ftsZ did not significantly impact cell growth or physiology ( Figure S1B ; Table S1 ).
The dose-dependent effect of cerulenin on cell size suggests a proportional relationship between size and fatty acid synthesis. To clarify this relationship, we took advantage of E. coli cells defective in fabH, encoding the enzyme catalyzing the initiating condensation reaction in fatty acid synthesis (b-ketoacyl-acyl carrier protein synthase III). Such cells are viable due to the presence of an uncharacterized bypass mechanism [15] . If cell size is proportional to fatty acid synthesis, the relationship between nutrient availability and cell size should be partially retained in a fabH mutant due to the presence of the putative bypass mechanism. In support of this reasoning, growth rate and cell size of fabH mutants increased with carbon availability, although not to the same extent or in the same manner as wildtype E. coli. In the poorest medium, AB-succ, a = 2.04 mm 2 ; in AB-caa-glc and AB-caa-succ, a = 2.15 mm
2
; and in the richest medium, LB-glc, a = 2.54 mm 2 ( Figure 1C ; Table S1 ). Interestingly, length remained relatively constant across growth conditions, but width changed substantially (LB-glc: w = 1.05 mm; AB-succ: w = 0.83). These findings run counter to those of Yao et al., who reported that the length and width of fabH mutants were essentially identical in rich or minimal media (LB and M63 minimal salts + 0.2% glucose) ( Figure S1 and Tables S1  and S2 .
Fatty Acid Availability Impacts Size via Changes in Plasma Membrane Capacity To clarify whether defects in fatty acid synthesis impact size via changes in plasma membrane capacity, we compared wildtype E. coli with isogenic strains defective in import (DfadL) or esterification (DfadD) of exogenous long chain fatty acids to their acyl-CoA form-both of which are required for incorporation of exogenous fatty acids into the plasma membrane-or an isogenic strain defective in b-oxidation (DfadE), which is required for utilization of fatty acids as a carbon source [27] .
Consistent with plasma membrane capacity being limiting for cell size, 10 mg/ml of oleic acid partially corrected the growth rate and size defects of cerulenin-treated wild-type and DfadE mutant cells. In contrast, growth rate and size of DfadL or DfadD mutants were unaffected, suggesting that oleic aciddependent increases in size were mediated through its incorporation into the plasma membrane (Figures 2A and 2B ; Tables  S4 and S6) .
Intriguingly, oleic acid also complemented the modest reduction in cell size associated with defects in protein synthesis. Consistent with the idea that chloramphenicol impacts size indirectly via reductions in levels of fatty acid synthesis enzymes, oleic acid partially corrected the growth rate and cell size defects of cells cultured in 1.5 mg/ml chloramphenicol, which were on average 10% larger and grew 15% faster in the presence of 10 mg/ml oleic acid than in its absence ( Figure 2C ; Table S4 ). Cell width remained essentially unchanged (w = 1.10 ± 0.03). The minimal inhibitory concentration (MIC) of chloramphenicol was unchanged with or without oleic acid, demonstrating that the increase in size in the presence of oleic acid does not result from reduced potency of the drug (Table S5 ).
Fatty Acid Availability Is an Evolutionarily Conserved Determinant of Cell Size
Using an approach essentially identical to that described above, we identified fatty acid synthesis as the primary biosynthetic determinant of size in the model Gram-positive bacterium B. subtilis. B. subtilis length in LB-glc + cerulenin (3.5 mg/ml) was reduced by $35% (untreated: l = 4.67 mm; + cer: l = 2.96 mm), and width remained constant, consistent with previous reports [16] . Chloramphenicol resulted in a modest ($10%) reduction in length, whereas rifampicin had no detectable impact on B. subtilis cell size ( Figure 3A ; Table S3 ). Addition of 2 mg/ml oleic acid increased the size of cerulenintreated cells by $30%. In contrast to E. coli, oleic acid increased untreated B. subtilis cell length by $10% in LB-glc ( Figure S2 ; Table S4 ), suggesting that fatty acids are limiting for membrane synthesis in this organism, even during growth in rich medium. Table S4 ).
Cell Size Scales with Fatty Acid Synthesis
To determine whether fatty acids are a positive determinant of cell size, we increased fatty acid production and measured the effect on cell size. We employed an IPTG-inducible plasmid, pE8k-fadR (hereafter pFadR) to overexpress the gene encoding FadR, a dual transcriptional regulator that activates fatty acid synthesis and represses b-oxidation [29, 30] .
Consistent with a positive relationship between fatty acid synthesis and cell size, induction of fadR led to a dose-dependent increase in cell size. At 10 mM IPTG, pFadR cells were nearly twice the size of wild-type cells (pFadR 10 mM IPTG: a = 7.03 mm Table S7 ). Induction of fadR alleles whose products are unable to bind DNA (F74G and W75G [31] ) had no impact on cell size ( Figure S3 ; Table S7 ), suggesting that cell size is not increasing simply due to a global increase in protein production, as has been observed in other inducible systems [32, 33] .
Intriguingly, induction of fadR inverted the relationship between size and growth rate. Although pFadR cells were approximately twice as large as the parental strain, they grew nearly 30% slower (Table S7 ). This is most likely a consequence of reductions in other anabolic pathways due to increased lipid synthesis. Importantly, induction of fadR did not significantly impact the ratio of ppGpp to GTP, consistent with a model in which fatty acid synthesis influences size independent of ppGpp ( Figures  S4A and S4B ).
Cell Size Increases with Phospholipid-Available Fatty Acid Levels
The correlation between cell size and fatty acid synthesis suggests that cell size is limited by the size of the fatty acid pools available for phospholipid synthesis. Increases in fatty acid syn- subtilis in LB-glc with subinhibitory concentrations of rifampicin (1.25, 2.5, 5, and 7.5 ng/ml), chloramphenicol (0.6, 0.7, and 0.8 mg/ml), or cerulenin (2, 3, 3.5, and 4 mg/ml). (B) B. subtilis cell size distributions and mean square areas in LB-glc after inhibition of fatty acid synthesis with 3.5 mg/ml cerulenin ± 2 mg/ml OA. (C) S. cerevisiae cell size distributions and mean square areas in YEPD medium after inhibition of fatty acid synthesis with 0.22 mg/ml cerulenin or cerulenin + 50 mg/ml OA. n R 3 experiments; n R 100 cells measured per experiment. All error bars indicate the SEM. See also Figure S2 and Tables S3 and S4. thesis should thus increase cell membrane production and cell size.
To test this idea, we measured total phospholipid-available fatty acids per cell (phospholipid bound or acyl-ACP thioesters) in wild-type and pFadR E. coli. Cells were cultured in LB-glc to an OD 600 of 0.15-0.3, and then we extracted the membranes, derivatized the phospholipid-available fatty acids to fatty acid methyl esters (FAMEs) by base catalysis, and quantified them using a gas-chromatography-flame ionization detector (GC-FID) [34] . As expected, phospholipid-available fatty acid content increased with cell size ( Figure 4E ). Wild-type cells contained an average of 4.95 3 10 À7 mg of phospholipid-available fatty acids per cell. In the presence of 5 mM IPTG, pFadR cells were $50% larger by square area than wild-type cells and contained $6.5-fold more phospholipidavailable fatty acids, whereas in the presence of 10 mM IPTG, cells were $75% larger with $25-fold more phospholipidavailable fatty acids. In all samples, we only detected long-chain fatty acids (C14, C16, and C18), as expected for fatty acids derived from E. coli phospholipids. The level of increase in phospholipidavailable fatty acids suggests that overproduction of FadR may lead to the formation of plasma membrane invaginations. To determine whether these samples contain excess membrane, we stained wild-type and pFadR cells with FM4-64 and MitoTracker Green FM. Although FM4-64 staining was peripheral in both wild-type and FadR overproducing cells, consistent with its being limited to the outer membrane, MitoTracker revealed possible internal lipid structures in pFadR cells ( Figure S5 ). Imaging by transmission electron microscopy (TEM) revealed the presence of excess membrane within pFadR cells, much of which appears to be formed from invagination of the plasma membrane ( Figure 4F ).
To further clarify the relationship between fatty acid synthesis, membrane capacity, and cell size, we utilized 'TesA, a cytosolic variant of E. coli acyl-CoA thioesterase I. 'TesA cleaves longchain fatty acyl-ACPs, shunting them away from phospholipid synthesis and into the extracellular medium [30, 35] . In support of a direct relationship between phospholipid synthesis and cell size, induction of 'tesA largely negated the increase in size imparted by expression of fadR alone. Cells carrying pFadR reached 5.0 and 6.5 mm 2 in the presence of 5 and 10 mM IPTG, respectively, whereas pFadR/p'TesA cells were 4.0 and 4.4 mm 2 on average ( Figure 5B ; Table S7 ).
Lipid Synthesis Impacts Cell Size Downstream of ppGpp
Mutations or antibiotics that interfere with early steps in fatty acid synthesis lead to increases in ppGpp levels due to reductions in SpoT hydrolase activity [36, 37] . As a global regulatory molecule, ppGpp inhibits expression of a host of genes, including those encoding ribosomal RNAs and genes essential for fatty acid and phospholipid synthesis [17, 29, 38] . These mutations or antibiotics may thus impact size indirectly via a ppGpp-dependent but fatty acid-independent mechanism. To confirm whether lipid synthesis impacts size downstream of ppGpp, we assessed the ability of FadR to overcome the size defect associated with increases in ppGpp. If ppGpp medi- To increase ppGpp levels, we utilized a plasmid (pALS10 hereafter pRelA) encoding the ppGpp synthase relA under the control of an IPTG-inducible promoter [19] . Consistent with previous studies, ppGpp negatively impacted cell size and growth rate [39] . In the absence of inducer, pRelA cells were on average 25% smaller than the parental strain (pRelA: a = 2.94 mm whereas those cultured in AB-caa-glc had a mean square area of 3.01 mm 2 and those in AB-caa-succ had a mean square area of 3.46 mm 2 ( Figure 6B ; Table S1 ). Although we observed some extremely long ppGpp 0 cells during growth in LB and LB-glc, such cells were absent during growth in minimal medium ( Figure S6 ). Although not essential in wild-type E. coli, fabH is absolutely required in strains with a defective SpoT allele [15] . Given this relationship, we wondered whether an increase in intracellular ppGpp levels in response to defects in fatty acid synthesis might be protective in E. coli, downregulating other aspects of biosynthesis to ensure that accumulation of cytoplasmic material does not exceed the capacity of the plasma membrane. To test this possibility, we examined the viability and membrane integrity of wild-type and ppGpp 0 cells cultured in the presence of a high concentration of the normally bacteriostatic antibiotic cerulenin (500 mg/ml cerulenin; approximately five times the MIC for wild-type cells). Supporting a protective role for the alarmone, ppGpp 0 cells were four orders of magnitude more sensitive to cerulenin than wild-type cells. Consistent with bacteriostatic activity, the plating efficiency of wild-type E. coli was largely unchanged in the presence of 500 mg/ml cerulenin. In contrast, ppGpp 0 cell plating efficiency dropped 10,000-fold over the course of 2.5 hr ( Figure 7A) .
To assess the impact of cerulenin on cell envelope integrity, we visualized uptake of propidium iodide (PI) in wild-type and ppGpp 0 cells after cerulenin addition. When bound to nucleic acids, the fluorescence intensity of PI increases 20-to 30-fold. Due to its large size, however, PI requires pores of at least 2 nm to enter cells, a size generally incompatible with viability [41] . Consistent with results in B. subtilis [16] , PI staining strongly supports the idea that ppGpp accumulation preserves E. coli membrane integrity in response to inhibition of fatty acid synthesis by regulating other aspects of macromolecular synthesis. The majority of ppGpp 0 cells exhibited severe loss of membrane integrity 3 hr after the addition of cerulenin (Figure 7C ). In contrast, only a few PI-positive wild-type cells were visible. Fluorescence intensity values suggest that wild-type cells were largely impermeable, whereas ppGpp 0 cells readily incorporated PI. The mean fluorescence intensity of ppGpp 0 mutants reached $50 a.u./cell within 60 min of cerulenin treatment and rose to 450 a.u./cell at 2.5 hr ( Figure 7B ). Importantly, we did not observe a similar increase in PI uptake in ppGpp 0 cells treated with either rifampicin or chloramphenicol ( Figure S7 ), suggesting that the loss of plasma membrane integrity is uniquely associated with defects in fatty acid synthesis.
DISCUSSION
This study establishes fatty acid synthesis, and by extension cell membrane capacity, as the primary biosynthetic determinant of E. coli cell size. Increasing fatty acid synthesis led to increases in cell size, whereas inhibiting fatty acid synthesis caused dosedependent reductions in cell size that were ameliorated by the addition of exogenous fatty acids (Figures 1, 2, 3, and 4) . In support of a direct relationship between membrane capacity and cell size, FadR-dependent increases in fatty acid synthesis increased both phospholipid content and cell size (Figures 4A-4F) . Conversely, diverting fatty acids from phospholipid synthesis via production of 'TesA counteracted the impact of FadR overproduction on cell size ( Figure 5 ). Defects in other major biosynthetic pathways either reduced size in a lipid-dependent manner (protein synthesis) or did not reduce cell size (RNA synthesis) (Figures 1, 2, and 3) .
A direct relationship between fatty acid synthesis and cell size provides a potential explanation for both the observation that bacterial cells add a constant volume each generation under steady-state conditions and the striking exponential relationship between nutrient availability and cell size [4, 5] . During balanced growth, a constant rate of fatty acid synthesis coupled with a relatively invariant cell-cycle clock translates into the addition of a constant volume in each generation. Shifting cells to carbon-rich medium increases the synthesis of fatty acids, which are almost entirely directed to the plasma and outer membranes [42] , altering the balance between biosynthetic capacity and cellcycle progression until a new equilibrium is established, albeit at a larger size (D). This model is supported by data indicating that In the absence of ppGpp, cells are unable to downregulate other anabolic pathways in response to defects in lipid synthesis, causing cell volume to outpace cell envelope capacity, which leads to cell lysis. See also Figure S7 .
the rate of fatty acid synthesis is proportional to carbon availability [43, 44] . This study is the first to definitively place lipid synthesis downstream of ppGpp with regard to cell size. Inducing expression of fadR not only increased the size of wild-type cells, but also overcame the size defect associated with increases in ppGpp (Figures 4 and 6) . The relationship between cell size and nutrient availability was retained in cells defective in ppGpp production, further reinforcing the idea that lipid synthesis is a primary determinant of cell size independent of the alarmone ( Figure 6B ).
Changes in Lipid Synthesis
Mimic the Impact of Nutrients on Cell Size and Morphology E. coli cultured in nutrient-poor medium were up to $30% shorter and $25% thinner than their counterparts cultured in nutrient-rich medium (Figure 1 ). Cells cultured in LB-glc with 70 mg/ml of cerulenin exhibited a 20% reduction in length and a 10% reduction in width, in total a 30% reduction in square area that rendered them essentially indistinguishable from their counterparts cultured in AB-caa-glc. Overproduction of FadR increased length by 60% and width by 15%, increasing square area $2-fold, a change proportional to that observed in wildtype E. coli cells shifted from AB-succ to LB-glc (Figures 1  and 4 ; Tables S1 and S7). The impact of lipid synthesis on length and width distinguishes it from the relationship between cell-cycle progression and cell size. Inhibiting division can dramatically increase cell length; however, width is largely unaffected and in some cases may even be reduced [32, 45] . Delaying DNA replication initiation by depleting DnaA similarly leads to significant increases in cell length, but not width [46] .
ppGpp Coordinates Lipid Synthesis with Other Aspects of Anabolic Metabolism to Preserve Cell Envelope Integrity
A role for plasma membrane capacity as a primary determinant of cell size has far reaching implications for other aspects of cellular physiology that respond to nutrient availability. Lipid synthesis must be coordinated with other biosynthetic processes to link surface area expansion with increases in cytoplasmic volume and maintain cell envelope integrity. Our data suggest ppGpp ensures that fatty acid synthesis is coupled to other biosynthetic processes (Figure 7) .
Given the global impact of ppGpp on biosynthetic capacity, it seems likely that the loss of cell envelope integrity in ppGpp 0 cells challenged with cerulenin results from the breakdown of coordination between multiple processes that are co-regulated by ppGpp. It is straightforward to imagine how unchecked RNA and protein synthesis in ppGpp 0 cells might lead cytoplasmic volume to outpace membrane capacity under conditions inhibiting fatty acid synthesis. In support of this idea, Pulschen et al. compared the rate of protein synthesis in cerulenin-treated ppGpp 0 and wild-type B. subtilis and found that synthesis continues at an elevated pace in the absence of ppGpp [16] . Loss of cell envelope integrity may also result from defects in coordination between lipid and cell wall synthesis, as ppGpp downregulates enzymes required for cell wall synthesis [47] . Independent of ppGpp, the reliance of peptidoglycan synthesis on availability of the 55-carbon lipid carrier, undecaprenyl pyrophosphate, may render it intrinsically dependent on central carbon metabolism.
Our measurements of phospholipid-available fatty acids and electron micrographs displaying plasma membrane invaginations in FadR overproducing cells demonstrate that plasma membrane expansion can exceed cytoplasmic volume, implying that the ppGpp-dependent coupling between fatty acid synthesis and cytosolic biosynthesis only functions in an inhibitory manner ( Figures 4E and 4F ).
Lipids as Conserved Determinants of Cell Size
Our data support the idea that lipid synthesis and, by extension, membrane capacity are widely conserved links between nutrient availability and cell size. Cerulenin reduced cell size of the Gramnegative model bacterium E. coli, the Gram-positive model bacterium B. subtilis, and the yeast S. cerevisiae (Figures 1, 2, and 3) . In prokaryotes, our data suggest that ppGpp modulates cell size by controlling the pool of lipids available for plasma membrane biogenesis and coordinates lipid synthesis with other aspects of biosynthetic capacity to preserve cell envelope integrity. In eukaryotes, target of rapamycin (TOR) kinase promotes cell growth and proliferation in part by stimulating lipid synthesis for both cell membrane synthesis and storage purposes [48] . Whether TOR plays a role analogous to ppGpp in mediating eukaryote cell size remains to be seen.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All experiments with E. coli were performed with MG1655 background strains. Deletions were constructed by P1 transduction of kanamycin marked alleles from the Keio collection BW25113 background strains into MG1655. E. coli was cultured at 37 C in lysogeny broth (LB) + 0.2% glucose or AB minimal medium supplemented with 10 mg/ml thiamine, 5 mg/ml thymidine and 0.5% casamino acids, 0.2% glucose or 0.4% succinate as indicated. Strains carrying plasmid pFadR were cultured with 50 mg/ml kanamycin as required. Strains carrying p‛TesA or pRelA were cultured with 100 mg/ml ampicillin. Cells were sampled for measurements at early exponential growth phase (OD 600 = 0.15-0.3) unless stated otherwise. To achieve balanced growth, cells were cultured at 37 C in the indicated medium from a single colony to early exponential phase with shaking (200 rpm). Cultures were then back-diluted into fresh medium to an OD 600 of 0.005 and cultured to early exponential phase prior to being sampled and fixed for analysis. For experiments in minimal medium, cells were first cultured from a single colony overnight prior to being back-diluted into minimal medium to an OD 600 of 0.005 and subjected to an additional round of growth and back-dilution as above. In experiments utilizing sub-inhibitory concentrations of rifampicin, chloramphenicol or cerulenin to inhibit RNA, protein or fatty acid synthesis, antibiotics were added when cultures were back-diluted. When indicated, isopropyl b-D-1-thiogalactopyranoside (IPTG) or exogenous fatty acids were added along with antibiotics at the indicated concentrations. B. subtilis experiments were performed with a JH642 wild-type strain. Cells were sampled for measurements at early exponential growth phase (OD 600 = 0.15-0.3) unless stated otherwise. To achieve balanced growth, cells were cultured at 37 C in LB + 0.2% glucose from a single colony to early exponential phase with shaking (200 rpm). Cultures were then back-diluted into fresh medium to an OD 600 of 0.005 and cultured to OD 600 = 0.15-0.3 prior to being sampled and fixed for analysis. Yeast experiments were performed with a S. cerevisiae W303 wild-type strain. Cells were grown overnight in YEPD liquid medium (1% yeast extract, 2% peptone, and 2% dextrose supplemented with 40 mg/L adenine) or YEPD containing 1 mM cerulenin ± 50 mg/ml oleic acid at 25 C until they reached early logarithmic phase (OD 600 0.2-0.4).
METHOD DETAILS
Cell size analysis E. coli was cultured as indicated in the experimental model details section and collected at early exponential phase (OD 600 = 0.15-0.3). E. coli cell membranes were labeled by adding 2 mL of 1 mg/ml FM4-64 fx to 250 mL of culture, then incubated for 4 min at room temperature. Cells were fixed by adding 10 mL of 1M NaPO4, pH 7.4, and 50 mL of fixative (fixative = 1 mL 16% paraformaldehyde + 6.25 mL 8% glutaraldehyde). Samples were incubated at room temperature for 15 min, then on ice for 30 min. Fixed cells were pelleted, washed three times in 1 mL 1X PBS, pH 7.4, then resuspended in 50 mL of GTE buffer (glucose-tris-EDTA) and stored at 4 C. Images were acquired for analysis within 48 hr. Cell length and width were determined from phase contrast images using the ImageJ plugin Coli-Inspector. FM4-64 fx membrane stain was employed to differentiate between cells that had completed division and those that had not. Length and width measurements from R 300 cells from R 3 biological replicates were used to generate single data points and histograms for each condition. For analysis of cell-cycle progression, cells were considered positive for FtsZ-ring formation if they contained a visible band across the width of the cells, two spots of GFP-FtsZ at midcell, or if a single spot of GFP-FtsZ was visible at the midpoint of an invaginating septum.
B. subtilis cells were cultured in LB-glc as indicated in the experimental model details section and fixed according to the same protocol used to fix E. coli. Following fixation, cells were immobilized on 15 well slides. Wells were treated for 5 min with 10 mL of 1% poly-L-lysine solution, then washed once with ddH 2 O. On a parafilm strip, fixed B. subtilis cells were treated for 1 min with lysozyme (10 mL of fixed cells + 10 mL of 20 mg/ml lysozyme stock), then transferred to the poly-L-lysine treated wells and left to adhere for 2 min. Adherent cells were washed once with 1X PBS. Cell walls were then labeled with 10 mL of wheat germ agglutinin-tetramethylrhodamine solution (1 mL of WGA (1 mg/ml) in 200 mL of 2% BSA (in PBS) solution) for 30 min at room temperature. Cells were then washed 10 times with 1X PBS, followed by one drop of SlowFade equilibration buffer and incubated for 5 min. Wells were covered with one drop of SlowFade Gold antifade and topped with a coverslip. Samples were covered and stored at À20 C. Images were acquired for analysis within 48 hr. Cell length was measured manually using Nikon NIS-Elements AR. Length was determined by measuring from pole-to-pole of single cells, or from septum-to-septum of cells that grew in chains.
S. cerevisiae were cultured as indicated in the experimental model details section. To fix S. cerevisiae, a 900 mL sample of early log phase culture (OD 600 = 0.2-0.4) was mixed with 100 mL of 37% formaldehyde for 1 hr, then washed twice with PBS containing 0.04% sodium azide and 0.02% Tween-20. Cell size was measured using a Coulter counter (Channelizer Z2; Beckman Coulter). 100 mL of fixed culture was diluted in 10 mL diluent (Isoton II; Beckman Coulter) and sonicated for 3 s to disperse any aggregates before cell size analysis. Each plot is the average of three independent biological replicates. For each biological replicate, three independent technical replicates were analyzed for each condition.
Fluorescent labeling of lipids E. coli was cultured in LB-glc as indicated in the experimental model details section. 75 min after back-dilution, 0.2 mM Mitotracker Green FM was added to each sample to label lipids. Cells were cultured in the presence of Mitotracker for $45-60 min until the samples reached early exponential phase (OD 600 = 0.15-0.3). E. coli outer membranes were labeled by adding 2 mL of 1 mg/ml FM4-64 fx to 250 mL of each early exponential phase culture, incubated for 4 min at room temperature, then placed on 1% agarose/LB pads and imaged.
Microscopy and image analysis
Phase contrast and fluorescence images were acquired from samples on 1% agarose/PBS pads (E. coli) or 15 well slides (B. subtilis) with an Olympus BX51 microscope equipped with a 100X Plan N (N.A. = 1.25) Ph3 objective (Olympus), X-Cite 120 LED light source (Lumen Dynamics), and an OrcaERG CCDcamera (Hammamatsu Photonics, Bridgewater, N.J.). Filter sets for fluorescence were purchased from Chroma Technology Corporation. Nikon Elements software (Nikon Instruments) was used for image capture. TEM images were acquired on a JEOL 1200 EX transmission electron microscope (JEOL USA, Peabody, MA) equipped with an AMT 8 megapixel digital camera and AMT Image Capture Engine V602 software (Advanced Microscopy Techniques, Woburn, MA).
Transmission electron microscopy sample preparation E. coli MG1655 and MG1655-pFadR were cultured at 37 C in LB-0.2% glucose from a single colony to OD 600 = 0.15-0.3 with shaking (200 rpm). Cultures were then back-diluted into fresh medium to an OD 600 of 0.005, at which point MG1655-pFadR samples were induced with the indicated concentrations of IPTG, cultured to OD 600 = 0.15-0.3, and then fixed. 1 mL of culture was pelleted for 5 min at 5,000 x g, washed once in 1X PBS, then resuspended in fixative (3% PFA/1% tannic acid/100mM cacodylate buffer) and incubated for 1 hr with gentle rocking at room temperature. After fixation, samples were washed 3 times over the course of a few hours. Secondary fixation was performed with 1% osmium tetroxide/16.5 mg/ml potassium ferricyanide/100 mM cacodylate buffer for 1 hr at room temperature, then washed 3 times in dH2O and stored overnight at 4 C. Samples were then en bloc stained with 1% aqueous uranyl acetate (Ted Pella, Redding, CA) for 1 hr. Following several rinses in dH 2 0, samples were dehydrated in a graded series of ethanol and embedded in Eponate 12 resin (Ted Pella). Sections of 95 nm were cut with a Leica Ultracut UCT ultramicrotome (Leica Microsystems, Bannockburn, IL), then stained with uranyl acetate and lead citrate (Ted Pella).
FadR mutagenesis
FadR variants FadR F74G and W75G were constructed using the PCR-based QuickChange site-directed mutagenesis kit (Agilent), using plasmid pE8k-fadR as a template. Mutagenic primer sequences are listed in the Key Resources Table. Minimal inhibitory concentration assays E. coli were cultured in LB-glc at 37 C with shaking (200 rpm) to early exponential phase as described in the experimental model details section. Cultures were then back-diluted into fresh medium to an OD 600 of 0.005 and cultured to OD 600 $0.1. 10 4 bacteria were added to wells of a 96 well plate containing 2-fold dilutions of chloramphenicol or cerulenin and cultured for 12 hr in LBglc ± 5 or 10 mg/ml oleic acid at 37 C with shaking. OD 600 values were acquired every 15 min in a BioTek Eon plate reader. MICs were calculated as the lowest antibiotic concentration preventing growth Measurement of steady-state intracellular nucleotides by thin layer chromatography Strains were grown from single colonies in low-phosphate MOPS (Teknova) at 37 C with shaking (1X MOPS, 1 mM KH 2 PO 4 , 0.2% glucose, 0.4% casamino acids) and appropriate antibiotics to early logarithmic phase, then diluted to OD 600 = 0.005, at which time 32 P-orthophosphate was introduced to label the cells. Once cells reached early logarithmic phase again, samples were collected for nucleotide extraction using 2M ice cold formic acid. Nucleotides were measured using thin layer chromatography and quantified using ImageQuant software (Molecular Dynamics) [51] . Intensities were normalized to the number of phosphates in the corresponding nucleotide. ppGpp levels are normalized to GTP level at steady state with signals from steady-state (p)ppGpp 0 cells subtracted.
Fatty acid extraction and quantification
Phospholipid-available (both phospholipid-bound and acyl-thioester species) fatty acids were extracted and methylated by base catalysis [34] . Fatty acids were extracted from 5 mL of early exponential phase culture spiked with 5 mL of 10 mg/ml methyl nonadecanoate. Cultures were mixed with 100 mL acetic acid followed by 5 mL of chloroform:methanol (1:1), vortexed thoroughly, and centrifuged for 10 min at 1000 x g. The upper aqueous layer and cell debris were aspirated, and the remaining chloroform extract was evaporated under a nitrogen stream, followed by lyophilization to remove any residual water. 0.5 mL of 0.5 M sodium methoxide in methanol was added to the dried extract, then incubated for 10 min at 50 C to derivatize phospholipid-available fatty acids to fatty acid methyl esters (FAMEs). The extracts were cooled to room temperature and the reactions were quenched with 100 mL of glacial acetic acid, followed by 5 mL of deionized water. Reactions were mixed with 0.5 mL of hexane to extract FAMEs, vortexed thoroughly, then centrifuged for 10 min at 1000 x g. The hexane extraction step was performed twice, transferring the hexane layer after centrifugation to a gas chromatography vial each time. FAMEs were analyzed using a gas chromatograph (Hewlett-Packard 6890, Agilent Technologies), equipped with a 30 m DB5-MS column (J&W Scientific) and a flame ionization detector (FID) (Agilent Technologies). FAME concentrations were determined by comparing the area under each FAME peak to standard curves generated from F.A.M.E. standard mixtures (GCL-20 and GLC-30) spiked with methyl nonadecanoate as an internal standard. To estimate the level of unwanted conversion of free fatty acids to FAMEs, we spiked samples with 50 mg of either C17 free fatty acid or C17 fatty acid methyl ester. While some C17 free fatty acid was recovered, it was only $15% of the amount of C17 FAME recovered, indicating that the overwhelming majority of material in our preparations was derived from phospholipid-bound or acyl-thioester fatty acids, not free fatty acids. Average fatty acid concentrations were determined for each condition in biological triplicate.
Cell viability assays
Cells were grown in LB-0.2% glucose at 37 C from a single colony to OD 600 = 0.2-0.3, back-diluted to OD 600 = 0.005, and returned to 37 C with shaking. At OD 600 $0.4, cultures were divided equally and exposed to either 500 mg/ml cerulenin, an equal volume of 95% EtOH as a solvent control or left untreated. Serial dilutions of each sample were spread on LB agar every 30 min after treatment. Colony forming units (CFUs) were enumerated after 24 hr of incubation at 37 C. Because ppGpp 0 cells tend to accumulate suppressor mutations in RNA polymerase, ppGpp 0 samples were plated on AB-minimal + 0.2% glucose and LB agar to identify suppressor mutants. The frequency of ppGpp 0 suppressor mutants was calculated as the ratio of CFU/ml recovered on minimal versus LB plates.
Data was only included from experiments where the ratio of CFU/ml recovered on minimal versus LB plates was less than 1:10.
Propidium iodide incorporation assays
Cells were grown in LB-0.2% glucose at 37 C from a single colony to OD 600 = 0.2-0.3, back-diluted to OD 600 = 0.005, and returned to 37 C. At OD 600 $0.4, cultures were divided equally and exposed to either 1.5 mM propidium iodide alone, or propidium iodide and either 500 mg/ml cerulenin or an equal volume of 95% EtOH as a solvent control. At indicated intervals, samples were removed and mounted on 1% agarose pads for phase contrast and fluorescence imaging. Propidium iodide incorporation was quantified using Nikon NIS-Elements AR. Fluorescence images were background corrected, bacteria from phase contrast images were outlined as regions of interest (ROIs) and the average fluorescence intensity per cell of the ROIs was determined from background corrected fluorescence images.
QUANTIFICATION AND STATISTICAL ANALYSIS
A minimum of three independent biological replicates (n = number of biological replicates) were performed for each experimental condition, R 100 cells measured per condition for each experiment unless otherwise noted in the corresponding figure legend. Data were expressed as means ± standard errors of the means (SEM). Statistical tests were performed in excel using the Analysis ToolPak add-in. Significance was calculated using standard two-tailed unpaired t tests assuming equal or unequal variances as determined by an F-test. No statistical methods were used to predetermine the size of datasets. Asterisks indicate a significant difference between the results for indicated experimental conditions (*, p < 0.05; **, p < 0.01).
